BioCentury

7:00 AM GMT, Apr 11, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Avastin bevacizumab: Postmarketing study data

There were no significant differences in the risk of myocardial infarction (MI) or ischemic cerebrovascular accident between treatment groups. The authors of the study said the data suggest differences in the safety profiles

Read the full 339 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.